AtriCure

ATRC · NASDAQ

$57.67+$2.14 (+3.85%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $55.53

Latest news

Press releaseOct 13, 8:00 AM ETBusiness Wire
AtriCure to Announce Third Quarter 2026 Financial Results
Press releaseSep 4, 7:15 PM ETPRNewswire
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
NewsSep 2, 10:26 AM ETAvi Kapoor
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
Press releaseAug 25, 8:00 AM ETBusiness Wire
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
NewsJul 29, 8:45 AM ETAvi Kapoor
Top 3 Health Care Stocks That May Implode This Month
Press releaseJul 27, 8:00 AM ETBusiness Wire
AtriCure to Participate at Upcoming Investor Conferences
NewsJul 23, 5:39 PM ET
AtriCure Reports Q2 2026 Results: Full Earnings Call Transcript
NewsJul 23, 4:02 PM ET
AtriCure Q2 Adj. EPS $0.18 Beats $0.00 Estimate, Sales $153.600M Beat $151.842M Estimate
Press releaseJul 23, 4:01 PM ETBusiness Wire
AtriCure Reports Second Quarter 2026 Financial Results
NewsJul 23, 7:11 AM ET
Earnings Scheduled For July 23, 2026
Press releaseJul 2, 8:00 AM ETBusiness Wire
AtriCure to Announce Second Quarter 2026 Financial Results
Press releaseMay 27, 8:00 AM ETBusiness Wire
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
NewsMay 5, 5:33 PM ET
AtriCure Q1 2026 Earnings Call Transcript
NewsMay 5, 4:04 PM ET
AtriCure Lowers FY2026 Adj EPS Guidance from $0.09-$0.15 to $0.00-$0.04 vs $0.07 Est; Affirms FY2026 Sales Guidance of $600.000M-$610.000M vs $604.053M Est
NewsMay 5, 4:02 PM ET
AtriCure Q1 Adj. EPS $0.00 Beats $(0.06) Estimate, Sales $141.249M Beat $139.812M Estimate
Press releaseMay 5, 4:01 PM ETBusiness Wire
AtriCure Reports First Quarter 2026 Financial Results
Press releaseApr 28, 8:00 AM ETBusiness Wire
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
Press releaseApr 14, 8:00 AM ETBusiness Wire
AtriCure to Announce First Quarter 2026 Financial Results
Press releaseFeb 24, 8:00 AM ETBusiness Wire
AtriCure to Participate in the Citizens Life Sciences Conference
NewsFeb 18, 5:00 PM ET
Demystifying AtriCure: Insights From 6 Analyst Reviews
Press releaseFeb 17, 4:01 PM ETBusiness Wire
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
NewsFeb 16, 3:01 PM ET
Insights into AtriCure's Upcoming Earnings
Press releaseJan 27, 8:00 AM ETBusiness Wire
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
Press releaseJan 16, 11:40 AM ETGlobe Newswire
AI Diagnostics: The End of the High-Cost Imaging Era
Press releaseJan 12, 10:21 AM ETBusiness Wire
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
Press releaseDec 17, 8:00 AM ETBusiness Wire
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
Press releaseDec 11, 8:00 AM ETBusiness Wire
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
Press releaseNov 18, 8:00 AM ETBusiness Wire
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
Press releaseOct 29, 4:01 PM ETBusiness Wire
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
Press releaseOct 28, 8:00 AM ETBusiness Wire
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
Press releaseOct 27, 8:00 AM ETBusiness Wire
AtriCure to Participate in Upcoming Investor Conferences
Press releaseOct 8, 8:00 AM ETBusiness Wire
AtriCure to Announce Third Quarter 2025 Financial Results
Press releaseSep 9, 8:00 AM ETBusiness Wire
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation
Press releaseAug 20, 8:00 AM ETBusiness Wire
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
NewsJul 29, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseJul 29, 4:01 PM ETBusiness Wire
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

AtriCure to Announce Third Quarter 2026 Financial Results

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

AtriCure to Participate in the 2026 Wells Fargo Health Care Conference

Top 3 Health Care Stocks That May Implode This Month

AtriCure to Participate at Upcoming Investor Conferences

AtriCure Reports Q2 2026 Results: Full Earnings Call Transcript

AtriCure Q2 Adj. EPS $0.18 Beats $0.00 Estimate, Sales $153.600M Beat $151.842M Estimate

AtriCure Reports Second Quarter 2026 Financial Results

Earnings Scheduled For July 23, 2026

AtriCure to Announce Second Quarter 2026 Financial Results

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

AtriCure Q1 2026 Earnings Call Transcript

AtriCure Lowers FY2026 Adj EPS Guidance from $0.09-$0.15 to $0.00-$0.04 vs $0.07 Est; Affirms FY2026 Sales Guidance of $600.000M-$610.000M vs $604.053M Est

AtriCure Q1 Adj. EPS $0.00 Beats $(0.06) Estimate, Sales $141.249M Beat $139.812M Estimate

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

AtriCure to Announce First Quarter 2026 Financial Results

AtriCure to Participate in the Citizens Life Sciences Conference

Demystifying AtriCure: Insights From 6 Analyst Reviews

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

Insights into AtriCure's Upcoming Earnings

AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results

AI Diagnostics: The End of the High-Cost Imaging Era

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference

AtriCure Announces the First Patients Treated with Novel Dual Energy Platform

AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference

AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025

AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial

AtriCure to Participate in Upcoming Investor Conferences

AtriCure to Announce Third Quarter 2025 Financial Results

AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation

AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference

12 Health Care Stocks Moving In Tuesday's After-Market Session

AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025